tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

Amneal Pharmaceuticals raises 2023 adjusted EPS view to 51c-58c from 45c-55c

Consensus for 2023 EPS is 55c. Raises 2023 revenue to $2.37B-$2.42B from $2.30B-$2.40B, consensus $2.37B.

Elevate Your Investing Strategy:

  • Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

See the top stocks recommended by analysts >>

Read More on AMRX:

Disclaimer & DisclosureReport an Issue

1